OVERVIEW OF LACTATE DEHYDROGENASE (LDH) ENZYME ACTIVITY IN HYPERTENSIVE PATIENTS WITH OBESITY AT TANGERANG DISTRICT HOSPITAL
DOI:
https://doi.org/10.61843/jondpac.v3i2.998Keywords:
Lactate Dehydrogenase Enzyme Activity, LDH, Hypertension, ObesityAbstract
Hypertension is a condition characterized by abnormally high blood pressure. One of the modifiable risk factors for hypertension is obesity. With increased body mass, the heart must pump blood harder, resulting in elevated blood pressure. One type of damage experienced by hypertension sufferers is endothelial dysfunction, which can be a predictor of atherosclerosis. This damage results in the release of the LDH enzyme into the blood. This study aims to determine the overview of LDH enzyme activity in hypertensive patients with obesity at the Tangerang District Hospital. The research design was descriptive and was conducted from March to May 2025. The data collection technique utilized purposive sampling with 26 respondents. The examination method used was the IFCC method. The results showed that LDH enzyme activity in hypertensive patients was high in 8 people (31%). Based on age, high results predominantly occurred in the pre-elderly group (46-60 years) with 5 people (63%). Based on gender, high results were primarily found in women, amounting to 7 people (88%). Based on obesity status, 8 people (100%) with Obesity I had high results. Based on antihypertensive medication consumption, high results were predominantly found in the amlodipine group with 5 people (63%). Future researchers can explore other unexplored factors such as physical activity, dietary patterns, and a history of vitamin C or alcohol consumption.
Downloads
References
1. Z. S. Annisa, Rudiyanto, and Sholihin, “Efektifitas Terapi Bekam Pada Penderita Hipertensi:,” vol. 1, no. 109, pp. 36–41, 2021.
2. Susaldi, P. Rahayu, and M. R. Okstoria, “Penerapan Senam Hipertensi dan Rebusan Air Daun Salam untuk Hipertensi,” J. Pengabdi. Masy. Saga Komunitas, vol. 2, no. 2, pp. 182–189, 2023, doi: 10.53801/jpmsk.v2i2.104.
3. WHO, “Hypertension,” World Health Organization. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/hypertension
4. Riskesdas, Laporan Nasional Riskesdas 2018. 2018.
5. N. J. Alfalah, D. Hasni, B. Y. Febrianto, and N. Warlem, “Hubungan Obesitas dengan Kejadian Hipertensi pada Perempuan Minangkabau,” Poltekita J. Ilmu Kesehat., vol. 15, no. 4, pp. 360–364, 2022, doi: 10.33860/jik.v15i4.823.
6. D. Rahmadi, A. Miarta, and R. Mafiana, “Peran Lactate Dehydrogenase (LDH) terhadap Prognosis Pasien Preeklampsia/ Eklampsia,” Palembang, 2024.
7. Y. Priwahyuni, C. V. Gloria, A. Alamsyah, and Ikhtiyaruddin, “Konseling Kenali Gejala Dan Jauhi Perilaku Berisiko Penyakit Hipertensi Di Masyarakat Rt 05 Rw 12 Kelurahan Tangkerang Selatan Kota Pekanbaru Tahun 2020,” J. Pengabdi. Kesehat. Komunitas ( J. Community Heal. Serv. ), vol. 1, no. 1, 2021.
8. Nurhikmawati, I. Afiifah, Feby Irsandy SYahruddin, Ali Aspar, and Indah Lestari Daeng Kanang, “Karakteristik Pasien Hipertensi dengan Gangguan Kardiovaskular,” Fakumi Med. J. J. Mhs. Kedokt., vol. 4, no. 7, pp. 513–520, 2024, doi: 10.33096/fmj.v4i7.479.
9. P2PTM Kemenkes RI, “Apa saja faktor risiko Hipertensi? Yuk, simak.,” PENYAKIT TIDAK MENULAR INDONESIA. [Online]. Available: https://p2ptm.kemkes.go.id/infographic-p2ptm/hipertensi-penyakit-jantung-dan-pembuluh-darah/page/2/apa-saja-faktor-risiko-hipertensi-yuk-simak
10. L. Badriyah and R. I. R. Pratiwi, “Hubungan Obesitas dengan Kejadian Hipertensi dan Hiperglikemia di Indonesia,” Ghidza J. Gizi dan Kesehat., vol. 8, no. 1, pp. 33–38, 2024, doi: 10.22487/ghidza.v8i1.1021.
11. X. Cai, T. Wang, and L. Xie, “Lactate dehydrogenase is associated with flow-mediated dilation in hypertensive patients,” Sci, vol. 13, 2023, doi: https://doi.org/10.1038/s41598-023-27614-3.
12. N. S. Harahap and D. R. Marpaung, “Sains Olahraga : Jurnal Ilmiah Ilmu Keolahragaan RESPON LAKTAT DEHIDROGENASE (LDH) SETELAH AKTIFITAS FISIK INTENSITAS BERAT PADA TIKUS PUTIH (RATTUS NORVEGICUS),” 2021, [Online]. Available: http://jurnal.unimed.ac.id/2012/index.php/so
13. U. A. Nurhayati, A. Ariyanto, and F. Syafriakhwan, “Hubungan Usia Dan Jenis Kelamin Terhadap Kejadian Hipertensi,” Pros. Semin. Nas. Penelit. Dan Pengabdi. Kpd. Masy. LPPM Univ. ’Aisyiyah Yogyakarta, vol. 1, pp. 363–369, 2023.
14. F. Ostadi, B. C. Anzali, and H. R. Mehryar, “Relationship between serum lactate dehydrogenase levels and prognosis in patients infected with omicron and delta variants of COVID-19: A cross-sectional study,” Toxicol. Reports, vol. 11, no. October, pp. 368–373, 2023, doi: 10.1016/j.toxrep.2023.10.003.
15. V. M. P. Rochira and C. M. Carani, Estrogens, Male Reproduction and Beyond. 2023. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK278933/
16. L. Yu et al., “Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China,” Diabetes, Metab. Syndr. Obes. , vol. 18, pp. 345–361, 2025, doi: 10.2147/DMSO.S492153.
17. T. Y. Johari, M. A. Ghoneim, and S. S. Moselhy, “Thyroid profile and LDH Isoenzymes as prognostic biomarkers for diabetic and/or obese subjects,” Afr Heal. Sci, vol. 3, pp. 697–706, 2018, doi: 10.4314/ahs.v18i3.28.
18. M. Jayanti, D. A. Mpila, and Y. A. Hariyanto, “Potensi Efek Samping Obat Antihipertensi di Puskesmas Kota Manado,” Optim. Peran Farm. dalam Ter. dan Pencegah. Penyakit Degener. pada Usia Produktif, pp. 1–6, 2023.
19. S. Bhargavi, “How to Reduce LDH Level?,” Apollo 24/7. [Online]. Available: https://www.apollo247.com/health-topics/general-medical-consultation/how-to-reduce-LDH-level
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Maheswari Syifa Puspamurti, Ramadas A
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Noncommunicable Diseases Prevention and Control applies the Creative Commons Attribution 4.0 International (CC BY) License, or other comparable licenses that allow free and unrestricted use to articles we publish. If you submit your manuscript for publication by the Journal of Noncommunicable Diseases Prevention and Control, you agree to have the CC BY license applied to your work. If your institution or funder requires your work or materials to be published under a different license or dedicated to the public domain - for example, Creative Commons 1.0 Universal (CC0) or Open Governmental License - this is permitted for those licenses where the terms are equivalent to or more permissive than CC BY.
